a-L-Fucosidase Detection Kit (CNPF Substrate Method) - NMPA Registration 京械注准20242400449
Access comprehensive regulatory information for a-L-Fucosidase Detection Kit (CNPF Substrate Method) in the China medical device market through Pure Global AI's free database. This Class II medical device is registered under NMPA registration number 京械注准20242400449 and owned by Beijing Homa Biological Engineering Co., Ltd.. The device was approved on February 04, 2025.
This page provides complete registration details including registrant information, province location (Beijing), intended use, and regulatory compliance data from the official China NMPA medical device database. Pure Global AI offers free access to China's complete medical device registry, helping global MedTech companies navigate NMPA regulations efficiently.
该产品用于体外定量测定人血清中alpha;-L-岩藻糖苷酶(AFU)的活性.
该产品用于体外定量测定人血清中alpha;-L-岩藻糖苷酶(AFU)的活性。
试剂1(R)组成:柠檬酸缓冲液、2-氯-4-硝基苯-a-L-岩藻吡喃糖苷、乙二胺四乙酸二钠;质控品(液体)组成:质控品(水平1):柠檬酸缓冲液、a-L-岩藻糖苷酶;质控品(水平2):柠檬酸缓冲液、a-L-岩藻糖苷酶.
试剂1（R）组成：柠檬酸缓冲液、2-氯-4-硝基苯-a-L-岩藻吡喃糖苷、乙二胺四乙酸二钠；质控品（液体）组成：质控品（水平1）：柠檬酸缓冲液、a-L-岩藻糖苷酶；质控品（水平2）：柠檬酸缓冲液、a-L-岩藻糖苷酶。